| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |